167 related articles for article (PubMed ID: 11894007)
1. Future directions for gemcitabine in the treatment of genitourinary cancer.
Vogelzang NJ
Semin Oncol; 2002 Feb; 29(1 Suppl 3):40-5. PubMed ID: 11894007
[TBL] [Abstract][Full Text] [Related]
2. [Gemcitabine and urogenital tumors].
Culine S
Bull Cancer; 2002 Aug; 89 Spec No():S102-6. PubMed ID: 12449039
[TBL] [Abstract][Full Text] [Related]
3. [Geriatric urology -- tumour diseases].
Krege S; Friedrich C; Pientka L; Rübben H
Aktuelle Urol; 2006 Jan; 37(1):45-51. PubMed ID: 16440246
[TBL] [Abstract][Full Text] [Related]
4. Brief communication: use of the multitargeted antifolate pemetrexed (Alimta) in genitourinary cancer.
Misset JL
Semin Oncol; 2002 Feb; 29(1 Suppl 3):36-9. PubMed ID: 11894006
[TBL] [Abstract][Full Text] [Related]
5. Current and future perspectives in advanced bladder cancer: is there a new standard?
von der Maase H
Semin Oncol; 2002 Feb; 29(1 Suppl 3):3-14. PubMed ID: 11894002
[TBL] [Abstract][Full Text] [Related]
6. Current concepts in genitourinary oncology: a multidisciplinary approach.
Rubin P
J Urol; 1971 Sep; 106(3):315-38. PubMed ID: 5107052
[No Abstract] [Full Text] [Related]
7. Genitourinary cancer.
Ozols RF; Yagoda A
Cancer Chemother Biol Response Modif; 1988; 10():271-90. PubMed ID: 2856330
[No Abstract] [Full Text] [Related]
8. Descriptive epidemiology of genitourinary cancers.
Pack R
Semin Oncol Nurs; 1993 Nov; 9(4):218-23. PubMed ID: 8290817
[TBL] [Abstract][Full Text] [Related]
9. A review of therapeutic strategies for phase I-II trials in genitourinary cancer.
Friedman MA
Recent Results Cancer Res; 1980; 70():203-10. PubMed ID: 7188814
[No Abstract] [Full Text] [Related]
10. Genitourinary cancer.
Hudes GR; Ozols RF; Schilder RJ
Cancer Chemother Biol Response Modif; 1991; 12():509-48. PubMed ID: 1718377
[No Abstract] [Full Text] [Related]
11. [Early detection of urogenital cancers: kidney, bladder, prostatic and testicular cancers].
Kawai T; Yamauchi T; Tachibana Y; Yoshino S; Kokuho M
Gan No Rinsho; 1988 Aug; 34(10):1403-7. PubMed ID: 3172497
[TBL] [Abstract][Full Text] [Related]
12. Role of multidrug resistance in tumors of the genitourinary tract.
Theyer G; Hamilton G
Urology; 1994 Dec; 44(6):942-50. PubMed ID: 7985331
[No Abstract] [Full Text] [Related]
13. Genitourinary cancer: a brief review.
Merrill JM
Compr Ther; 1981 Mar; 7(3):40-4. PubMed ID: 7195323
[No Abstract] [Full Text] [Related]
14. Gemcitabine for unresectable, locally advanced or metastatic bladder cancer.
Shelley M; Cleves A; Wilt TJ; Mason M
Cochrane Database Syst Rev; 2011 Apr; (4):CD008976. PubMed ID: 21491413
[TBL] [Abstract][Full Text] [Related]
15. Gemcitabine based trimodality treatment in patients with muscle invasive bladder cancer: May neutrophil lymphocyte and platelet lymphocyte ratios predict outcomes?
Hurmuz P; Ozyigit G; Kilickap S; Esen CSB; Akdogan B; Ozen H; Akyol F
Urol Oncol; 2021 Jun; 39(6):368.e19-368.e29. PubMed ID: 33189528
[TBL] [Abstract][Full Text] [Related]
16. Treatment of genitourinary tumours with cis-dichlorodiammineplatinum(II): experience in 250 patients.
Merrin CE
Cancer Treat Rep; 1979; 63(9-10):1579-84. PubMed ID: 574057
[No Abstract] [Full Text] [Related]
17. [Genitourinary manifestations of lymphoma].
Schultz A; Maruschke M; Leithäuser M; Seiter H
Aktuelle Urol; 2007 Jul; 38(4):324-7. PubMed ID: 17647171
[TBL] [Abstract][Full Text] [Related]
18. Gemcitabine in the treatment of bladder cancer.
Ryan CW; Vogelzang NJ
Expert Opin Pharmacother; 2000 Mar; 1(3):547-53. PubMed ID: 11249537
[TBL] [Abstract][Full Text] [Related]
19. Gemcitabine and other new chemotherapeutic agents for the treatment of metastatic bladder cancer.
Vogelzang NJ; Stadler WM
Urology; 1999 Feb; 53(2):243-50. PubMed ID: 9933034
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy of genitourinary malignancies.
Gordon RL
Semin Drug Treat; 1973; 3(1):69-72. PubMed ID: 4123696
[No Abstract] [Full Text] [Related]
[Next] [New Search]